Latest News

Kalbe Launches Mommychi Mother and Child Health Monitoring

A Child's Future is Determined on its First 1000 Days of Life

Kalbe Launches Mommychi Mother and Child Health Monitoring

Press Release No 001/KFCP/DIR/PR/I/14

Jakarta, 15 January 2014 – PT Kalbe Farma Tbk (Kalbe) today launches Mommychi, a mobile application to monitor the health of mother and child. The Application is the newest method to monitor the health of the mother and the child from the start of pregnancy through the child's first 1000 days.  Mommychi consists of a mobile application and a website for the mothers to access her pregnancy or their child's health records easily.  Mommychi features three parts, which are: Pregnancy Features (pregnancy control, journal, mother's encyclopedia, baby name generator); Child's Health Monitor (vaccination, child's health journal, growth chart, early detection of illnesses, child's encyclopedia); and the General Feature (gallery, directory, music, games, ask a doctor).

“The launch of this Application is part of Kalbe's care for a healthier Indonesia, to educate the communities on the importance of a healthy pregnancy and the children's health, as well as being parallel with the government's program of First 1000 Days of Life as an effort of achieving the Millennium Development Goals sooner. “ said Vidjongtius, Director of PT Kalbe Farma Tbk. “This Application will be continuously developed, and it is expected to increase Kalbe's Services for its consumers and providing other high quality health products.  We hope that the Mommychi mobile application will be the most important, trusted, and user-friendly health application.”

“The first 1000 days of life that started in the womb to two years of age is the critical period that determines the child's brain's development." said DR. Dr. Ahmad Suryawan, Sp.A(K), Chairman of the Division of Child and Adolescent Growth of the Department of Pediatric Health at Dr. Soetomo/FK Unair Surabaya Hospital (University of Airlangga Medical Faculty). “The uniqueness of this critical period lies on two things, which are the period of when the brain synapses are formed to up to 80%, and this is a once-in-a-lifetime period, therefore through this time, the Child should be constantly monitored to avoid failure of forming synapses that could permanently affect the child through its lifetime.”

Mommychi is an online apps (like Facebook), where the available data are stored securely in servers and can be accessed on line at any time using android or iOS operating systems. The data is highly individualized and confidential in accordance to the login name and password.   Users can integrate the child's data from inception to birth and then growth, simply by a press of a button (to link with pregnancy). Mommychi is equipped with numerous interactive tools, such as pregnancy journal, vaccination reminder that is linked to mother's mobile's calendar, growth chart with nutritional status, et cetera.

Mommychi is a part of KALCare health services, one of Kalbe's customer care units that provide an integrated healthcare solution. KALCare  provides a complete service including consultation with physicians, pharmacyst, laboratory, health check-up, information, and education, as well as health services with a personal touch. KALCare Outlets are currently available at Pondok Indah Mall2, Lotte Shopping Avenue, and Bintaro Exchange.  KALCare corner is also available at Supermall Karawaci and Hypermart Puri.  KALCare services can also be accessed at

Kalbe at a glance
PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio; prescription medicines (Cefspan, Brainact, Broadced, etc); health products division that handles over-the-counter medications (Woods, Promag, Mixagrip, Komix, Fatigon, etc) and ready-to-drink energy drinks (Hydro Coco, Extra Joss, Nitros), nutrition division (ChilKid, Prenagen, Diabetasol, etc); and distribution division. Kalbe currently has more than 20 subsidiaries, 11 production facilities with international standard, and employs more than 15,000 employees and 4,000 sales force and marketing agents, dispersed across more than 65 branches throughout Indonesia. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX:KLBF).

2578 Rate this article:

Please login or register to post comments.